clinical trial · NCT06776432
Safety and Efficacy Study of Sivopixant, Acetazolamide and SASS-001 in Sleep Apnea
Apnimed·phase2·recruiting·n = 60
Sleep ApneaSivopixantPlaceboAcetazolamideSASS-001
brief summary
The primary purpose of this study is to evaluate the effectiveness of sivopixant, acetazolamide and SASS-001 in adults with sleep apnea with a central component.
started
Apr 2, 2025
primary completion
Dec 1, 2025
completion
Dec 1, 2025
last updated
Oct 16, 2025
official title
A Phase 2A Double-Blind Randomized, Controlled, Dose Escalation, Parallel- Arm, Safety and Efficacy Study of Sivopixant, Acetazolamide and SASS-001 in Sleep Apnea
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol